Young James Emmett 4
4 · TriSalus Life Sciences, Inc. · Filed Feb 6, 2025
Insider Transaction Report
Form 4
Young James Emmett
Chief Financial Officer
Transactions
- Purchase
Common Stock
2025-02-05$5.65/sh+6,000$33,900→ 30,000 total(indirect: By Trust)
Holdings
- 21,726
Common Stock
Footnotes (1)
- [F1]The Reporting Person is the sole trustee of Kathleen A. Young Living Trust.